View of The Potential of Folate-Positive Circulating Tumor Cells (FR+-CTC) as a Novel Diagnostic Biomarker for Non-Small Cell Lung Cancer

Return to Article Details The Potential of Folate-Positive Circulating Tumor Cells (FR+-CTC) as a Novel Diagnostic Biomarker for Non-Small Cell Lung Cancer Download Download PDF